Prairie Capital Acquires Cantor BioConnect, Seraplex, and Dx Biosamples to Form Leading Platform in the Biopharma and Diagnostics Industries

We represented Prairie Capital, a private equity firm focused on guiding high-potential, founder-owned companies on the journey to becoming scalable platforms prepared for accelerated growth, in its acquisition of Cantor BioConnect, Seraplex, and Dx Biosamples, biotechnology and healthcare companies specializing in providing biospecimens and contract research organization services to the diagnostic and biopharmaceutical industries, to create a leading life sciences platform.

We represented Prairie Capital, a private equity firm focused on guiding high-potential, founder-owned companies on the journey to becoming scalable platforms prepared for accelerated growth, in its acquisition of Cantor BioConnect, Seraplex, and Dx Biosamples, biotechnology and healthcare companies specializing in providing biospecimens and contract research organization services to the diagnostic and biopharmaceutical industries, to create a leading life sciences platform.